Zurueck zur Suche

Reporte zur Charge 2NK52

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

2Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
NH 1

VAERS 1481020

GLAXOSMITHKLINE BIOLOGICALS · HEP B (ENGERIX-B) · Charge 2NK52

gering
Staat
-
Alter
50,0
Geschlecht
F
Eingang
17.07.2021
Impfdatum
10.07.2021
Beginn
10.07.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Received an Engerix-B dose that had expired; This case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 50-year-old female patient who received HBV (Engerix B) (batch number 2NK52, expiry date 28th February 2021) for prophylaxis. On 10th July 2021, the patient received Engerix B. On 10th July 2021, unknown after receiving Engerix B, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. Additional details were reported as follows: On 10th July 2021, patient received a dose of Engerix B, which was expired on February 2021. The reporter consented to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1312749

GLAXOSMITHKLINE BIOLOGICALS · HEP B (ENGERIX-B) · Charge 2NK52

gering
Staat
NH
Alter
50,0
Geschlecht
M
Eingang
13.05.2021
Impfdatum
10.05.2021
Beginn
10.05.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

Patient received an expired dose of Engerix-B on 10May2021; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 50-year-old male patient who received HBV (Engerix B) (batch number 2NK52, expiry date 20th February 2021) for prophylaxis. Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis. On 10th May 2021, the patient received the 1st dose of Engerix B and Engerix B Pre-Filled Syringe Device. On 10th May 2021, unknown after receiving Engerix B and Engerix B Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were reported as follows: it was reported that a male patient received an expired dose of Engerix-B on 10th May2021. The vaccine expired on 20th February 2021. No symptoms reported. The reporter consented to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-